Consano Bio, Inc. — Form D
Consano Bio, Inc. of BURLINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-20. The offering totals $48.9M, of which $34.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-03-20
- Form: D
- Accession: 0001981285-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $48.9M
- Amount sold: $34.8M
- Remaining: $14.0M
- Investors: 28
- Date of first sale: 2026-03-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-577172
Issuer
- Name: Consano Bio, Inc.
- CIK: 0001981285
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 100 SUMMIT DRIVE, BURLINGTON, MA, 01803
- Phone: 617-798-4559
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Christopher Vander Centeno | Director | Burlington, MA |
| John Vander Conway | Director | Burlington, MA |
| Michael Vander Pede | Director | Burlington, MA |
| Joe Vander Schiesl | Director | Burlington, MA |
| Bill Vander Abbington | Director | Burlington, MA |
| Jerome Vander Adams | Director | Burlington, MA |
| Doug Vander Weide | Director | Burlington, MA |
| Chris Vander Centeno | Director | Burlington, MA |
| Andrew Hall | Director | Chicago, IL |
| Andrew Hall | Executive Officer | Chicago, IL |
| Jennifer Schmitke | Executive Officer | Burlington, MA |
| Daniel Haders | Director | San Deigo, CA |
| WAYNE SCHELLHAMMER | Director | DES MOINES, IA |
| WAYNE SCHELLHAMMER | Executive Officer | DES MOINES, IA |
| CLAYTON HARTMAN | Director | DES MOINES, IA |
| NA REGENEXX HOLDINGS, LLC | Executive Officer | DES MOINES, IA |
Other filings by this issuer (2)
More